Company profile
Keylika
Revolutionizing treatment for Iron Deficiency Anemia.
- Industry
- Biotechnology
- Employees
- 3
- Headquarters
- Walnut Creek, CA
- Founded
- 2022
- LinkedIn followers
- 691
- Office locations
- 1
Keylika company summary
Keylika is a company in the Biotechnology industry, headquartered in Walnut Creek, CA, founded in 2022. On LinkedIn the company has around 3 employees and 691 followers. Its listed specialties include Bioinorganic drugs, organometallic drugs, drug delivery, transdermal, first principles design.
What technology does Keylika use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Keylika
Keylika is an early stage biopharma startup developing organometallic drugs using a proprietary platform synthesis technology, to treat unmet medical needs. We then administer these drugs using proven delivery technologies, to effect the best clinical outcomes. Positioned at the intersection of drug discovery and drug delivery, enables us to customize the molecular structure and/or formulation of a drug as well as the microsystems engineering component to optimally fit the most clinically advantageous mode of drug delivery. Our first product is a novel iron complex (new molecular entity) administered by a wearable transdermal patch. This is slated to be a best-in-class, breakthrough therapy for treating Iron Deficiency Anemia (IDA) without any GI side-effects (eg. nausea, constipation, diarrhoea, etc.) typically associated with oral iron supplements, and without risks associated with IV iron infusions. Eventually, this may serve to replace both oral as well as parenteral IV iron forms. Preliminary animal studies have shown excellent results. Our first target population is young women of child-bearing age suffering from heavy menstruation or menorrhagia and thus, severe IDA (population size: 6 million in the US). Iron deficiency is an understated problem affecting 30 million people in the US alone and 1.6 billion worldwide, with grossly suboptimal current solutions. Recently, we have been accepted at Y Combinator for the Summer 2022 cohort (starting in June).
Specialties
Where is Keylika located?
Keylika lists 1 location.
Compare companies similar to Keylika
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Keylika keylika.com | Biotechnology | 3 | 2022 | Walnut Creek, CA |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Keylika
What does Keylika do?
Keylika is an early stage biopharma startup developing organometallic drugs using a proprietary platform synthesis technology, to treat unmet medical needs. We then administer these drugs using proven delivery technologies, to effect the best clinical outcomes. Positioned at the intersection of drug discovery and drug delivery, enables us to customize the molecular structure and/or formulation of a drug as well as the microsystems engineering component to optimally fit the most clinically advantageous mode of drug delivery. Our first product is a novel iron complex (new molecular entity) administered by a wearable transdermal patch. This is slated to be a best-in-class, breakthrough therapy for treating Iron Deficiency Anemia (IDA) without any GI side-effects (eg. nausea, constipation, diarrhoea, etc.) typically associated with oral iron supplements, and without risks associated with IV iron infusions. Eventually, this may serve to replace both oral as well as parenteral IV iron forms. Preliminary animal studies have shown excellent results. Our first target population is young women of child-bearing age suffering from heavy menstruation or menorrhagia and thus, severe IDA (population size: 6 million in the US). Iron deficiency is an understated problem affecting 30 million people in the US alone and 1.6 billion worldwide, with grossly suboptimal current solutions. Recently, we have been accepted at Y Combinator for the Summer 2022 cohort (starting in June).
How many employees does Keylika have?
Keylika has around 3 employees on LinkedIn.
Where is Keylika headquartered?
Keylika is headquartered in Walnut Creek, CA.
When was Keylika founded?
Keylika was founded in 2022.
Build a lead list from companies like Keylika
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.